HTLV-1-associated myelopathy in Spain
Autor:
De-Mendoza, Carmen
; Pérez, Leire
; Rando, Ariadna
; Reina, Gabriel
; Aguilera, Antonio
; Benito, Rafael
; Eirós, José María
; Rodríguez-Avial, Itziar
; Ortega, Diego
; Pozuelo, María José
; Pena, María José
; Soriano, Vicente
Fecha:
2023Palabra clave:
Revista / editorial:
Journal of Clinical VirologyCitación:
de-Mendoza, C., Pérez, L., Rando, A., Reina, G., Aguilera, A., Benito, R., ... & Network, S. H. (2023). HTLV-1-associated myelopathy in Spain. Journal of Clinical Virology, 169, 105619.Tipo de Ítem:
Articulo Revista IndexadaResumen:
Background: HTLV-1 infection is a neglected disease. Over 10 million people are infected worldwide, with hot spots of high endemicity across all continents. Roughly 5% of HTLV-1 carriers develop HTLV-1-associated myelopathy (HAM), a progressive subacute neurological disabling disease.
Methods: We report the main features of patients diagnosed with HAM up to date in Spain, a non-endemic country with a relatively high migrant flow from Latin America and Equatorial Africa, where HTLV-1 is endemic.
Results: A total of 451 cases of HTLV-1 had been recorded in Spain until the end of year 2022. HAM had been diagnosed in 58 (12.9%). The current incidence is of 2–3 new cases per year. Women represent 76%. Mean age at diagnosis is 49 years-old. Nearly 60% are Latin Americans. Although sexual transmission is the most likely route of HTLV-1 acquisition, up to 6 individuals had been infected following solid organ transplantation. Rapid onset myelopathy developed in all but one of these transplant recipients from three HTLV-1-positive donors. HTLV-1 subtype 1a transcontinental was the only variant recognized in HAM patients. HTLV-1 proviral load was significantly greater in HAM patients than in asymptomatic HTLV-1 carriers (677 vs 104 HTLV-1 DNA copies/104 PBMC; p = 0.012). Symptom relief medications and physiotherapy have been the only treatment providing some benefit to HAM patients. Neither significant clinical nor virological efficacy was noticed using antiretrovirals in at least 9 HAM patients. Two thirds of HAM patients ended up in a wheelchair and with urinary/fecal sphincter incontinence.
Conclusion: HAM is the most frequent clinical manifestation of HTLV-1 infection in Spain, a non-endemic country. Middle aged women migrants from Latin America are the most frequently affected. Two thirds end up in a wheelchair despite using antiretroviral therapy.
Este ítem aparece en la(s) siguiente(s) colección(es)
Estadísticas de uso
Año |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Vistas |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
55 |
Descargas |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Late presentation of human T-lymphotropic virus type 1 infection in Spain reflects suboptimal testing strategies: on behalf of the Human T-lymphotropic Virus (HTLV) Spanish Network
de Mendoza, Carmen; Pérez, Leire; Fernández-Ruiz, Mario; Pena, María José; Ramos, José Manuel; Richart, Alberto; Pirón, María; Rando, Ariadna; Miró, Elisenda; Reina, Gabriel; Encinas, Beatriz; Rojo, Silvia; Rodriguez-Iglesias, Antonio Manuel; Benito, Rafael; Aguilera, Antonio; Treviño, Ana; Corral, Octavio Jorge; Soriano, Vicente (International Journal of Infectious Diseases, 2022)Objectives: Although only 10% of persons infected with human T-lymphotropic virus type 1 (HTLV-1) may develop virus-associated illnesses over their lifetime, missing the earlier diagnosis of asymptomatic carriers frequently ... -
The slowdown of new infections by human retroviruses has reached a plateau in Spain
de Mendoza, Carmen; Carrizo, Paula; Sauleda, Silvia; Richart, Alberto; Rando, Ariadna; Miró, Elisenda; Benito, Rafael; Ayerdi, Oscar; Encinas, Begoña; Aguilera, Antonio; Reina, Gabriel; Rojo, Silvia; González, Rocío; Fernández-Ruiz, Mario; Liendo, Paloma; Montiel, Natalia; Roc, Lourdes; Treviño, Ana; Pozuelo, María José; Soriano, Vicente (Journal of Medical Virology, 2023)The 2022 annual meeting of the HTLV & HIV-2 Spanish Network was held in Madrid on December 14. We summarize here the main information presented and discussed at the workshop and review time trends for human retroviral ... -
Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions
Mendoza, Carmen de; Rando, Ariadna; Miró, Elisenda; Pena, María José; Rodríguez-Avial, Iciar; Ortega, Diego; González-Praetorius, Alejandro; Reina, Gabriel; Pintos, Ilduara; Pozuelo, María José; Soriano, Vicente (Journal of Clinical Virology, 2023)Background: HTLV-1 infection is a neglected disease, despite producing neurological and lymphoproliferative severe illnesses and affect over 10 million people worldwide. Roughly 5% of HTLV-1 carriers develop Adult T-cell ...